Literature DB >> 30808273

LIM Kinase 1 Mediates Estradiol Effects on the Phosphorylation of Cofilin1 in Eutopic Endometrial Stromal Cells During the Invasion and Proliferation of Endometriosis.

Jing Liu1,2, Zhifang Zhang3,2, Jiamei Liu1, Danbo Wang1.   

Abstract

Endometriosis is an estrogen-dependent gynecological disease; however, the mechanism by which estradiol promotes the development of endometriosis, including invasion and proliferation, remains unclear. Estradiol is involved in cell invasion and proliferation by regulating the cytoskeleton. The abnormally high expression of cytoskeletal regulators (LIM kinase 1 [LIMK1] and cofilin1) is closely related to increased invasiveness and proliferation of eutopic endometrial stromal cells from endometriosis patients compared to normal eutopic endometrial cells. The aim of this study was to analyze the role of estradiol during invasion and proliferation through the LIMK1/cofilin1 pathway in the endometrium of women with endometriosis. To address this, primary eutopic endometrial stromal cells were isolated from the uteri of patients with endometriosis and cultured without estradiol. The phosphorylation of cofilin1 was analyzed by western blotting. Cell invasiveness and proliferation were evaluated following LIMK1 knockdown by RNA interference technology. We found that, before LIMK1silencing, the phosphorylation levels of cofilin1 and LIMK1 of eutopic endometrial stromal cells from endometriosis patients treated with estradiol were higher than cells not treated with estradiol (P < .05 and P < .01, respectively). The total levels of cofilin1 and LIMK1 protein did not change (P > .05 and P > .05, respectively). After LIMK1 silencing, the phosphorylation of cofilin1 by estradiol was significantly reduced, and invasiveness and proliferation were clearly and concurrently decreased (P < .05 and P < .05, respectively). Thus, the phosphorylation of cofilin1 by estradiol is mediated by LIMK1, and estradiol is involved in regulating cell invasion and proliferation in endometriotic patients through the LIMK1/cofilin1 pathway.

Entities:  

Keywords:  LIMK1; cofilin1; cytoskeleton; endometriosis; endometrium; estradiol; invasion; proliferation

Mesh:

Substances:

Year:  2019        PMID: 30808273     DOI: 10.1177/1933719119828076

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  7 in total

Review 1.  In-vitro models of human endometriosis.

Authors:  Hongjie Fan
Journal:  Exp Ther Med       Date:  2019-12-20       Impact factor: 2.447

2.  SMURF1-mediated ubiquitylation of SHP-1 promotes cell proliferation and invasion of endometrial stromal cells in endometriosis.

Authors:  Yunmeng Bian; Li Yuan; Xiaoqian Yang; Lichun Weng; Yanli Zhang; He Bai; Jinhong Chen
Journal:  Ann Transl Med       Date:  2021-03

3.  Knockdown of CCL28 inhibits endometriosis stromal cell proliferation and invasion via ERK signaling pathway inactivation.

Authors:  Yingting Wu; Feilong Zhu; Wenqin Sun; Weiwei Shen; Qin Zhang; Huifen Chen
Journal:  Mol Med Rep       Date:  2021-12-16       Impact factor: 2.952

Review 4.  The Role of LIM Kinase in the Male Urogenital System.

Authors:  Juhyun Park; Soo Woong Kim; Min Chul Cho
Journal:  Cells       Date:  2021-12-28       Impact factor: 6.600

5.  Effects of an inhibitor of the SHH signaling pathway on endometrial cells of patients with endometriosis.

Authors:  Yanan He; J Wang; Xinyan Jiang; Jianhua Gao; Yan Cheng; Tian Liang; Jun Zhou; Liyuan Sun; Guangmei Zhang
Journal:  BMC Mol Cell Biol       Date:  2022-08-06

6.  Nicotine promotes the development of oral leukoplakia via regulating peroxiredoxin 1 and its binding proteins.

Authors:  Moci Qi; Lingyu Li; Xiaofei Tang; Yunping Lu; Min Wang; Jing Yang; Min Zhang
Journal:  Braz J Med Biol Res       Date:  2021-05-31       Impact factor: 2.590

7.  Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.

Authors:  Guojun Lu; Ying Zhou; Chenxi Zhang; Yu Zhang
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.